Clinical Trials

The long-term commercial supply agreement between Lonza and Vertex Pharmaceuticals marks a pivotal moment in the field of gene therapy, promising significant advancements for patients suffering from sickle cell disease (SCD) and beta-thalassemia. This collaboration focuses on the production of

The clinical research landscape is on the cusp of a transformative shift with the U.S. Food and Drug Administration (FDA) poised to implement a groundbreaking regulation by May 2025. This regulation mandates the use of a single, centralized institutional review board (sIRB) for multisite trials,

Kaida BioPharma, an emerging pharmaceutical company based in Fort Lauderdale, Florida, has announced the launch of its new corporate social media channels. This significant development aims to enhance the company’s presence across various platforms, including X, LinkedIn, and Facebook. By l

GC Therapeutics (GCTx), a biotech company founded in 2019, has captured the spotlight with its pioneering approach to cell therapy. With a mission centered on advanced induced pluripotent stem cell (iPSC)-based medicines, GCTx is driven by its innovative TFome platform. Bolstered by a successful

The competitive landscape of pharmaceutical treatments for achondroplasia, a common cause of dwarfism, is experiencing a seismic shift, thanks to the recent clinical trial results from Ascendis Pharma. BioMarin Pharmaceutical, a long-time player in this niche market, finds itself under significant

In a significant move for maternal and neonatal healthcare, Danish biotech company MinervaX has teamed up with German CDMO Wacker Biotech to develop a groundbreaking prophylactic vaccine for Group B Streptococcus (GBS) infections. This partnership marks a pivotal step in addressing a critical unmet